Heart transplantation in amyloidosis. Clinical and imaging manifestations

IF 0.7 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS
Santiago Decotto, Eugenia Villanueva, Diego Pérez de Arenaza, Elsa M Nucifora, María A Aguirre, María L Posadas-Martínez, Ricardo G Marenchino, César A Belziti
{"title":"Heart transplantation in amyloidosis. Clinical and imaging manifestations","authors":"Santiago Decotto,&nbsp;Eugenia Villanueva,&nbsp;Diego Pérez de Arenaza,&nbsp;Elsa M Nucifora,&nbsp;María A Aguirre,&nbsp;María L Posadas-Martínez,&nbsp;Ricardo G Marenchino,&nbsp;César A Belziti","doi":"10.24875/ACM.21000191","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>To describe the clinical and imaging characteristics of heart transplantation patients due to amyloidosis in a community institution.</p><p><strong>Method: </strong>Descriptive case series of consecutive heart transplantation patients with amyloidosis in a medical center. All patients with diagnosis of amyloidosis with cardiac compromise receiving heart transplantation, performed in the period November 2008 to February 2021, were included in the analysis.</p><p><strong>Results: </strong>A total of 16 patients were included. The mean age was 59.9 years (± 10.2). 81.25% (n = 13) were male. According to the type of amyloidosis, 12 patients were transplanted for AL amyloidosis and 4 for ATTR amyloidosis. The most frequent clinical presentations were left overload (50%) and cardiogenic shock (32%). The mean ejection fraction prior to transplantation was 43% (± 16), 14 of the 16 patients had right ventricular dysfunction. The most common finding on cardiac magnetic resonance was the diffuse subendocardial late gadolinium enhancement pattern, with cancellation of the blood pool. The heart transplantation gave 6 patients the chance to receive a bone marrow transplantation afterwards.</p><p><strong>Conclusions: </strong>Heart transplantation has become an option for patients with heart failure due to AL and ATTR amyloidosis. In patients with AL amyloidosis, it might even allow bone marrow transplantation in a second stage.</p>","PeriodicalId":8360,"journal":{"name":"Archivos de cardiologia de Mexico","volume":null,"pages":null},"PeriodicalIF":0.7000,"publicationDate":"2022-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/f1/42/6936AX213-ACM-92-320.PMC9262297.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Archivos de cardiologia de Mexico","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.24875/ACM.21000191","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: To describe the clinical and imaging characteristics of heart transplantation patients due to amyloidosis in a community institution.

Method: Descriptive case series of consecutive heart transplantation patients with amyloidosis in a medical center. All patients with diagnosis of amyloidosis with cardiac compromise receiving heart transplantation, performed in the period November 2008 to February 2021, were included in the analysis.

Results: A total of 16 patients were included. The mean age was 59.9 years (± 10.2). 81.25% (n = 13) were male. According to the type of amyloidosis, 12 patients were transplanted for AL amyloidosis and 4 for ATTR amyloidosis. The most frequent clinical presentations were left overload (50%) and cardiogenic shock (32%). The mean ejection fraction prior to transplantation was 43% (± 16), 14 of the 16 patients had right ventricular dysfunction. The most common finding on cardiac magnetic resonance was the diffuse subendocardial late gadolinium enhancement pattern, with cancellation of the blood pool. The heart transplantation gave 6 patients the chance to receive a bone marrow transplantation afterwards.

Conclusions: Heart transplantation has become an option for patients with heart failure due to AL and ATTR amyloidosis. In patients with AL amyloidosis, it might even allow bone marrow transplantation in a second stage.

淀粉样变的心脏移植。临床及影像学表现
目的:描述某社区医院因淀粉样变性而接受心脏移植的患者的临床和影像学特点。方法:对某医疗中心连续心脏移植淀粉样变性患者进行描述性病例系列分析。所有在2008年11月至2021年2月期间接受心脏移植的淀粉样变性合并心脏损害的患者都被纳入分析。结果:共纳入16例患者。平均年龄59.9岁(±10.2岁)。81.25% (n = 13)为男性。根据淀粉样变性的类型,AL淀粉样变性12例,ATTR淀粉样变性4例。最常见的临床表现是左超载(50%)和心源性休克(32%)。移植前平均射血分数为43%(±16),16例患者中有14例存在右室功能不全。心脏磁共振最常见的发现是弥漫性心内膜下晚期钆增强模式,血池消失。心脏移植为6例患者术后提供了接受骨髓移植的机会。结论:心脏移植已成为AL和ATTR淀粉样变心力衰竭患者的一种选择。在AL淀粉样变患者中,它甚至可能允许在第二阶段进行骨髓移植。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Archivos de cardiologia de Mexico
Archivos de cardiologia de Mexico Medicine-Cardiology and Cardiovascular Medicine
CiteScore
0.80
自引率
20.00%
发文量
176
审稿时长
18 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信